|
MAPK14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83113999999707E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.858350E-03 |
| Normal-vs-Stage2 |
6.397900E-03 |
| Normal-vs-Stage3 |
3.19069999998867E-06 |
| Normal-vs-Stage4 |
8.003800E-04 |
| Stage1-vs-Stage2 |
2.878800E-01 |
| Stage1-vs-Stage3 |
3.430000E-02 |
| Stage1-vs-Stage4 |
1.545980E-01 |
| Stage2-vs-Stage3 |
6.801000E-01 |
| Stage2-vs-Stage4 |
9.005200E-01 |
| Stage3-vs-Stage4 |
7.698200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30409999999659E-05 |
| Normal-vs-AfricanAmerican |
1.83212999999016E-05 |
| Normal-vs-Asian |
8.591000E-01 |
| Caucasian-vs-AfricanAmerican |
7.211600E-02 |
| Caucasian-vs-Asian |
2.144200E-01 |
| AfricanAmerican-vs-Asian |
3.936200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74319999996153E-06 |
| Normal-vs-Female |
1.743440E-03 |
| Male-vs-Female |
1.468560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.559600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.455910E-03 |
| Normal-vs-Age(61-80Yrs) |
1.54054000000015E-05 |
| Normal-vs-Age(81-100Yrs) |
1.366150E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.911400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.663000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.068200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.085800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.309400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.140000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.631600E-01 |
| Normal-vs-Grade 2 |
9.858600E-03 |
| Normal-vs-Grade 3 |
1.19330000003526E-06 |
| Normal-vs-Grade 4 |
4.25889999999818E-05 |
| Grade 1-vs-Grade 2 |
2.169600E-01 |
| Grade 1-vs-Grade 3 |
2.752300E-02 |
| Grade 1-vs-Grade 4 |
2.307900E-02 |
| Grade 2-vs-Grade 3 |
1.078270E-02 |
| Grade 2-vs-Grade 4 |
1.408360E-02 |
| Grade 3-vs-Grade 4 |
4.984200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.857700E-02 |
| Normal-vs-ccB subtype |
1.50585999999509E-05 |
| ccA subtype-vs-ccB subtype |
1.562930E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.503080E-03 |
| Normal-vs-N1 |
5.108600E-01 |
| N0-vs-N1 |
8.398000E-01 |
|
|
